OpenEvidence Partners With ASAM to Integrate Addiction Treatment Guidelines Into AI Platform
Article excerpt
Highlighted: the sentence this signal was extracted from
The integration aims to give clinicians easier access to evidence-based recommendations when addressing addiction and substance use disorders. OpenEvidence has partnered with the American Society of Addiction Medicine (ASAM) to make clinical guidelines and implementation resources for substance use disorder and addiction treatment accessible through its AI-powered medical research platform for clinicians. Under the partnership, ASAM's clinical guidelines, guidance, and implementation resources will appear alongside peer-reviewed medical research on OpenEvidence, with citations and direct links to sources. The integration aims to give clinicians easier access to evidence-based recommendations when addressing addiction and substance use disorders. OpenEvidence, a Florida-based company, offers a free platform for U.S. clinicians that synthesizes medical literature to help answer clinical questions. ASAM represents more than 8,000 physicians, clinicians, and other professionals specializing in addiction medicine. The organization develops clinical guidance and resources to support evidence-based addiction prevention and treatment. The integration will bring ASAM's recommendations into clinicians' existing research workflows, allowing them to access professional guidance alongside published medical evidence through a single platform. OpenEvidence Expands Medical Publishing...
Keep reading with a free account
The rest of this article, and every signal for OpenEvidence, is in your free account.
